NewsInnovative Trials2024-11-25T12:21:32+00:00

IT logotype with strapline_on dark backgrounds 1300x264px

News

Stay updated with the latest news from Innovative Trials

Revolutionize patient recruitment and retention with Navigator

Phil Long2023-10-16T15:48:49+01:00October 9th, 2023|

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention Innovative Trials,

Innovative Trials partners up with Multiple Myeloma Research Foundation

Phil Long2023-09-26T09:26:14+01:00September 18th, 2023|

Innovative Trials to help advance blood cancer care and research with inaugural US charity partnership Innovative Trials, a

Innovative Trials partners up with Great Ormond Street Hospital Children’s Charity

Phil Long2023-08-16T15:45:17+01:00August 9th, 2023|

Innovative Trials to help advance children’s cancer care through new UK charity partnership Innovative Trials, a global clinical

Innovative Trials finalist in the Lloyd’s Bank British Business Excellence Awards

Phil Long2023-08-09T08:39:07+01:00August 3rd, 2023|

Innovative Trials shortlisted for prestigious British Business Excellence Award Innovative Trials, a global company specialising in clinical trial

Innovative Trials at the Inspire Hertfordshire Awards Gala Dinner

Phil Long2023-06-26T14:29:07+01:00June 23rd, 2023|

Innovative Trials among Hertfordshire companies celebrated at local business awards Innovative Trials, a global clinical trial patient recruitment

Innovative Trials Addresses UK Clinical Trial Decline in Response to National Recommendations

Phil Long2023-06-26T14:29:35+01:00June 5th, 2023|

Innovative Trials responds to national recommendations to tackle UK clinical trial decline Kate Shaw, the founder and CEO

Previous 234 Next

Learn more how we accelerate patient recruitment

Therapy Areas

We have extensive experience of study phases I to IV, adults and paediatrics and both acute and chronic conditions.

Analgesics

Intra Abdominal pain
Post Operative pain

General Medicine

Non Alcoholic Fatty Liver Disease (NAFLD)
Non Alcoholic Steatohepatitis (NASH)
Hypercholesterolaemia
Type II Diabetes

Haematology

Anaemia
Haemophilia
Sickle Cell
Thrombocytopenia

Bone

Osteoarthritis

Dermatology

Atopic Dermatitis
Hidradenitis Suppurativa
Psoriasis

Gastroenterology

Crohn’s Disease
Ulcerative Colitis

Infection

Bacterial infection – Sepsis
C-Diff
Intra-abdominal Infectious Disease
Pneumonia

Immunology

Ankylosing Spondylitis
Alopecia
Asthma
Atopic Dermatitis
Crohn’s Disease
Hidradenitis Suppurativa
Lupus
Nasal Polyps
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Vitiligo

Neuroscience/CNS

Alzheimer’s Disease
Epilepsy
Depression
Duchenne Muscular Dystrophy (DMD)
Dyskinesia in Cerebral Palsy
Migraine
Multiple Sclerosis
Parkinson’s Disease
Schizophrenia

Oncology

Acute Myeloid Leukaemia
Basal Cell Carcinoma
Bladder Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Head & Neck Cancer
Liver Cancer
Lung Cancer
Lymphoma
Metastatic Bone Pain
Myelofibrosis
Mutant Tumours
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Solid Tumour
Treatment Resistance Post Cancer Treatment
Urothelial Cancer

Respiratory

Asthma
COPD

Urology

Over-active Bladder

Vaccines

Pneumonia
Urinary Tract Infection

Vascular Disease

Stroke

Women’s Health

Birth Control
Interstitial Cystitis
STD Prevention
Urinary Tract Infection

Do you need to minimise the impact on your clinical trials, or boost patient recruitment in your Covid-19 studies?

Let’s talk

You are one step away from discovering how we can work side by side to support your patient recruitment needs.